NDC 68180-347 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68180-347
- Package NDCs from labels
- 68180-347-01
- Manufacturer
- Lupin Pharmaceuticals, Inc. | LUPIN LIMITED
- Effective date
- 2021-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam - Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2021-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68180-347-01 | Lorazepam | 1 in 1 CARTON | SOLUTION, CONCENTRATE | 1 | 5 | |
| 68180-347-01 | Lorazepam | 30 mL in 1 BOTTLE, DROPPER | SOLUTION, CONCENTRATE | 30 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quality Choice Lubricant Eye Drops High Performance | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Chain Drug Marketing Assoc., Inc. | 0cd1b36a-a07a-a1db-e063-6294a90a5994 | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Quality Choice Moisturizing Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Chain Drug Marketing Association, Inc. | 1fb81759-5931-59c8-e063-6294a90a2277 | 2025-12-30 | Warnings | B697894SGQ |
| Quality Choice Lubricant Eye Drops Long Lasting | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Chain Drug Marketing Assoc., Inc. | 0cd91c45-88a2-f88c-e063-6294a90ad127 | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Archies Dry Eye Relief | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Archie's Remedies | 07da099b-6b7f-984d-e063-6294a90a12ac | 2025-12-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Equaline Multi-Symptom Eye Drops | POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | United Natural Foods, Inc. | fe467606-6d66-b695-e053-6294a90aab5d | 2025-12-30 | Warnings | B697894SGQ |
| Walgreens Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4538-2061-e063-6394a90a6e73 | 2025-12-19 | Warnings | 6DC9Q167V3 B697894SGQ |
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | B697894SGQ |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | B697894SGQ |
| LORAZEPAM | LORAZEPAM | Aurolife Pharma LLC | 5b851f67-309d-4ef3-8b4b-ade8908256ea | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Splash Pure PF | PROPYLENE GLYCOL | LABORATORIOS SOPHIA, S.A. DE C.V. | 40ad7ae5-1f2a-e3b1-e063-6294a90a6f84 | 2025-11-26 | Warnings | 6DC9Q167V3 |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 6DC9Q167V3 |
| Lorazepam | LORAZEPAM | RedPharm Drug, Inc. | 891b2c10-942f-0e4d-e053-2995a90af028 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PharmPak, Inc. | b6e4d2c7-10c0-4d77-be7b-caa3d3b86997 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Systane Complete PF | PROPYLENE GLYCOL EMULSION | Alcon Laboratories, Inc. | 798ffdde-1dba-4a3f-a0b6-937f9e958cca | 2025-11-03 | Warnings | 6DC9Q167V3 |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | 6DC9Q167V3 |
| Walgreens Ultra Lubricant | POLYETHYLENE GLYCOL 400, AND PROPYLENE GLYCOL | Walgreens | 21dfe061-4533-2061-e063-6394a90a6e73 | 2025-10-17 | Warnings | 6DC9Q167V3 B697894SGQ |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 1f79a5a1-0c40-45cf-8994-51f5ba3a5938 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0681c8db-ff09-4258-a5e0-76a26b0ea0af | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7afd9a59-3463-4eda-8cf3-ef90be05de3d | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.